Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aminophylline for severe bronchiolitis in paediatric intensive care
ACTRN12608000608369Phase 4Terminated
- Sponsor
- Prof Frank Shann
- Start
- Oct 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in bronchiolitis comparing Aminophylline plus standard treatment with Placebo plus standard treatment (2 arms). Primary endpoint: Duration of respiratory support. Started Oct 2002; status: terminated.
02
Drugs
aminophylline
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on ACTRN12608000608369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000608369.